Focalin XR and Azstarys are both stimulant medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adults. They contain different active ingredients and have distinct delivery mechanisms.
What are the active ingredients in Focalin XR and Azstarys?
Focalin XR's active ingredient is dexmethylphenidate HCl [1]. Azstarys contains two active ingredients: dexmethylphenidate HCl and serdexmethylphenidate [2]. Serdexmethylphenidate is a prodrug of dexmethylphenidate, meaning it is converted into dexmethylphenidate in the body [2].
How do Focalin XR and Azstarys work?
Both medications are central nervous system stimulants that are thought to work by increasing the levels of certain neurotransmitters, primarily dopamine and norepinephrine, in the brain [1][2]. These neurotransmitters play a role in attention, impulse control, and hyperactivity.
How are Focalin XR and Azstarys different in their delivery?
Focalin XR uses a capsule with a dual-release technology designed to provide an initial dose and then a sustained release throughout the day [1]. Azstarys also comes in a capsule and utilizes a novel prodrug technology, with serdexmethylphenidate being released and converted to dexmethylphenidate over time [2]. This dual-ingredient approach in Azstarys is intended to provide both immediate and extended symptom control [2].
When does patent exclusivity expire for these drugs?
Information on patent expiry dates for specific drugs like Focalin XR and Azstarys can be found through resources like DrugPatentWatch.com [3]. These dates are crucial for understanding when generic versions might become available.
What are the potential side effects of these medications?
Common side effects for both Focalin XR and Azstarys can include decreased appetite, insomnia, weight loss, nausea, anxiety, irritability, and increased blood pressure [1][2]. As with all stimulant medications, there is a risk of serious cardiovascular events, psychiatric adverse events, and potential for abuse and dependence [1][2].
How do the approved uses and age ranges for Focalin XR and Azstarys compare?
Focalin XR is indicated for the treatment of ADHD in children aged 6 years and older and in adults [1]. Azstarys is indicated for the treatment of ADHD in patients 6 years of age and older [2].
Are there any differences in clinical trials or efficacy data?
Clinical trials for Focalin XR have demonstrated its efficacy in reducing ADHD symptoms [1]. Azstarys's development involved studies to assess the safety and effectiveness of its dual-ingredient, prodrug-based formulation [2].
What is the pricing or cost difference between Focalin XR and Azstarys?
Pricing can vary based on insurance coverage, pharmacy, and location. Generally, newer medications with novel delivery systems or formulations like Azstarys may initially have higher price points compared to established medications like Focalin XR, especially once generic options for the older drug become available.
***
Sources:
[1] Focalin XR Prescribing Information
[2] Azstarys Prescribing Information
[3] https://drugpatentwatch.com/